Neuroprotective effects of the GABAA receptor partial agonist U-101017 in 3-acetylpyridine-treated rats
- 1 May 1997
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 228 (1) , 45-49
- https://doi.org/10.1016/s0304-3940(97)00353-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Neuroprotective Properties of the Benzodiazepine Receptor, Partial Agonist PNU-101017 in the Gerbil Forebrain Ischemia ModelJournal of Cerebral Blood Flow & Metabolism, 1997
- Characterization of U-101017 as a GABAA receptor ligand of dual functionalityBrain Research, 1996
- Reduction of GABAA and GABAB receptor densities in the cerebellar cortex from 3-acetylpyridine-induced ataxic ratsBrain Research, 1994
- Role of the excitotoxic mechanism in the development of neuronal damage following repeated brief cerebral ischemia in the gerbil: protective effects of MK-801 and pentobarbitalBrain Research, 1990
- Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemiaNeuroscience Letters, 1988
- Central neurotoxic effects of intraperitoneally administered 3-acetylpyridine, harmaline and niacinamide in Sprague-Dawley and Long-Evans rats: A critical review of central 3-acetylpyridine neurotoxicityBrain Research Reviews, 1985
- Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral MicrodialysisJournal of Neurochemistry, 1984
- Mechanisms by which diazepam, muscimol, and other drugs change the content of cGMP in cerebellar cortexProceedings of the National Academy of Sciences, 1977
- Effects of 3-acetylpyridine on the central nervous system of the rat, as demonstrated by silver methodsBrain Research, 1974
- The Cerebellum as a Neuronal MachinePublished by Springer Nature ,1967